Report Summary
The global Tasigna market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Tasigna market based on company, product type, end user and key regions.
This report studies the global market size of Tasigna in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tasigna in these regions.
This research report categorizes the global Tasigna market by top players/brands, region, type and end user. This report also studies the global Tasigna market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Market size by Product
50mg
200mg
Other
Market size by End User
Hospital
Drugs Store
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tasigna market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Tasigna market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tasigna companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tasigna submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tasigna are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tasigna market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Tasigna Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tasigna Market Size Growth Rate by Product
1.4.2 50mg
1.4.3 200mg
1.4.4 Other
1.5 Market by End User
1.5.1 Global Tasigna Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Drugs Store
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tasigna Market Size
2.1.1 Global Tasigna Revenue 2017-2027
2.1.2 Global Tasigna Sales 2017-2027
2.2 Tasigna Growth Rate by Regions
2.2.1 Global Tasigna Sales by Regions
2.2.2 Global Tasigna Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Tasigna Sales by Manufacturers
3.1.1 Tasigna Sales by Manufacturers
3.1.2 Tasigna Sales Market Share by Manufacturers
3.1.3 Global Tasigna Market Concentration Ratio (CR5 and HHI)
3.2 Tasigna Revenue by Manufacturers
3.2.1 Tasigna Revenue by Manufacturers (2017-2020)
3.2.2 Tasigna Revenue Share by Manufacturers (2017-2020)
3.3 Tasigna Price by Manufacturers
3.4 Tasigna Manufacturing Base Distribution, Product Types
3.4.1 Tasigna Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tasigna Product Type
3.4.3 Date of International Manufacturers Enter into Tasigna Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Tasigna Sales by Product
4.2 Global Tasigna Revenue by Product
4.3 Tasigna Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Tasigna Breakdown Data by End User
6 North America
6.1 North America Tasigna by Countries
6.1.1 North America Tasigna Sales by Countries
6.1.2 North America Tasigna Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tasigna by Product
6.3 North America Tasigna by End User
7 Europe
7.1 Europe Tasigna by Countries
7.1.1 Europe Tasigna Sales by Countries
7.1.2 Europe Tasigna Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tasigna by Product
7.3 Europe Tasigna by End User
8 Asia Pacific
8.1 Asia Pacific Tasigna by Countries
8.1.1 Asia Pacific Tasigna Sales by Countries
8.1.2 Asia Pacific Tasigna Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tasigna by Product
8.3 Asia Pacific Tasigna by End User
9 Central & South America
9.1 Central & South America Tasigna by Countries
9.1.1 Central & South America Tasigna Sales by Countries
9.1.2 Central & South America Tasigna Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tasigna by Product
9.3 Central & South America Tasigna by End User
10 Middle East and Africa
10.1 Middle East and Africa Tasigna by Countries
10.1.1 Middle East and Africa Tasigna Sales by Countries
10.1.2 Middle East and Africa Tasigna Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tasigna by Product
10.3 Middle East and Africa Tasigna by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Tasigna Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Novartis Tasigna Products Offered
11.1.5 Novartis Recent Development
12 Future Forecast
12.1 Tasigna Market Forecast by Regions
12.1.1 Global Tasigna Sales Forecast by Regions 2021-2027
12.1.2 Global Tasigna Revenue Forecast by Regions 2021-2027
12.2 Tasigna Market Forecast by Product
12.2.1 Global Tasigna Sales Forecast by Product 2021-2027
12.2.2 Global Tasigna Revenue Forecast by Product 2021-2027
12.3 Tasigna Market Forecast by End User
12.4 North America Tasigna Forecast
12.5 Europe Tasigna Forecast
12.6 Asia Pacific Tasigna Forecast
12.7 Central & South America Tasigna Forecast
12.8 Middle East and Africa Tasigna Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tasigna Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
